YCBD vs CRON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 04, 2026

YCBD

37.4
AI Score
VS
CRON Wins

CRON

49.9
AI Score

Investment Advisor Scores

YCBD

37score
Recommendation
SELL

CRON

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric YCBD CRON Winner
Revenue 16.21M 98.22M CRON
Net Income -2.21M 45.84M CRON
Gross Margin 57.3% 48.5% YCBD
Net Margin -13.6% 46.7% CRON
Operating Income -2.22M 5.57M CRON
ROE -26.9% 4.3% CRON
ROA -16.8% 3.9% CRON
Total Assets 13.15M 1.18B CRON
Cash 2.12M 467.02M CRON
Current Ratio 2.50 16.18 CRON
Free Cash Flow -2.17M 31.29M CRON

Relative Price Performance (Last 90 Days)

YCBD 1M: +3.9% · 3M: -21.3% CRON 1M: +5.6% · 3M: +7.3%

Current Technical Phase

YCBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.2%), weak momentum, RSI 44

RSI (14): 43.8 · Price: $0.37

CRON

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.6 · Price: $3.38

Fundamentals Snapshot

Metric YCBD CRON
Market Cap — —
Forward P/E -2.0 13.3
Trailing P/E 1.7 21.3
Revenue (TTM) — —
Revenue Growth 0.2% 0.7%
Gross Margin 0.6% 0.5%
Operating Margin -0.1% 0.1%
EPS 0.23 0.16
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CRON is currently the stronger investment candidate, winning 10 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.